Patent Assignment
Reel/Frame 025150/0379
Security Agreement
Recorded: 2010-10-18
Received: 2010-10-18
Pages: 34
Assignor
ARYX THERAPEUTICS, INC.
Executed: 2010-08-13
Assignees
AYER CAPITAL PARTNERS MASTER FUND, L.P.
230 CALIFORNIA STREET, SUITE 600, AYER CAPITAL MANAGEMENT, L.P. ATTN: JAY VENKATESAN, SAN FRANCISCO, CA, 94111, UNITED STATES
MPM BIOVENTURES III, L.P.
200 CLARENDON STREET, 54TH STREET, BOSTON, MA, 02116, UNITED STATES
MPM BIOVENTURES III-QP, L.P.
200 CLARENDON STREET, 54TH STREET, BOSTON, MA, 02116, UNITED STATES
MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
200 CLARENDON STREET, 54TH STREET, BOSTON, MA, 02116, UNITED STATES
MPM BIOVENTURES III PARALLEL FUND, L.P.
200 CLARENDON STREET, 54TH STREET, BOSTON, MA, 02116, UNITED STATES
AYER CAPITAL PARTNERS KESTREL FUND, L.P.
200 CALIFORNIA STREET, SUITE 600, AYER CAPITAL MANAGEMENT, L.P. ATTN: JAY VENKATESAN, SAN FRANCISCO, CA, 94111, UNITED STATES
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC
200 CLARENDON STREET, 54TH FLOOR, BOSTON, MA, 02116, UNITED STATES
Covered Properties
(48)
D2 Antagonists, Methods of Synthesis and Methods of Use
Application:
61/356,096 →
Agonists of Peroxisome Proliferator Activated Receptor-Alpha
Application:
12/641,954 →
Methods for Treating Atrial Fibrillation
Application:
61/263,567 →
Methods for Stroke Reduction in Atrial Fibrillation Patients
Application:
61/263,564 →
Methods for Treating Atrial Fibrillation and Reducing Stroke Rate in Atrial Fibrillation Patients
Application:
61/263,465 →
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Application:
12/268,109 →
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
12/109,500 →
Dibenzo[B,F][1,4]Oxazapine Compounds
Application:
12/047,858 →
Materials and Methods for the Treatment of Gastroesophageal Reflux Disease
Application:
11/962,592 →
Ultrashort Acting Hypnotic Barbiturates
Application:
12/009,446 →
Novel Compounds For Treatment of Cardiac Arrhythmia and Methods of Use
Application:
11/936,620 →
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Application:
11/778,482 →
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
11/778,315 →
Novel 5-HT3 Receptor Antagonists and Methods of Use
Application:
11/551,562 →
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
11/469,264 →
Materials and Methods for Treating Coagulation Disorders
Application:
11/467,813 →
Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Application:
11/457,719 →
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Application:
11/423,559 →
Ultrashort-Acting Opioids for Transdermal Application
Application:
11/257,323 →
Materials and Methods for Treating Coagulation Disorders
Application:
11/101,714 →
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Application:
11/101,995 →
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
11/087,167 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
11/074,152 →
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
11/031,623 →
Materials and Methods for the Treatment of Depression
Application:
10/931,586 →
Materials and Methods for Treating Coagulation Disorders
Application:
10/822,129 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
10/799,546 →
Ultrashort-Acting Opioids for Transdermal Applications
Application:
10/771,483 →
Ultrashort Acting Hypnotic Barbiturates
Application:
10/763,904 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
10/759,617 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Application:
10/697,683 →
Materials and Methods for the Treatment of Hypertension and Angina
Application:
10/643,699 →
Novel 5-HT3 Receptor Antagonists and Methods of Use
Application:
10/348,669 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
10/319,073 →
Materials and Methods for the Treatment of Depression
Application:
10/273,702 →
Materials and Methods for the Treatment of Hypertension and Angina
Application:
10/269,139 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
10/251,522 →
Ultrashort Acting Hypnotic Barbiturates
Application:
10/145,601 →
Materials and Methods for Treating Coagulation Disorders
Application:
10/132,750 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Application:
10/123,573 →
Ultrashort-Acting Opioids for Transdermal Application
Application:
10/116,320 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
09/961,542 →
Isoxazolidine Compounds Useful in the Treatment of Diabetes, Hyperlipidemia, and Atherosclerosis in Mammals
Application:
09/961,538 →
Materials and Methods for the Treatment of Gastroesophageal Reflux Disease
Application:
09/876,698 →
Materials and Methods for the Treatment of Depression
Application:
09/841,749 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
09/841,351 →
Ultrashort Acting Hypnotic Barbiturates
Application:
09/841,738 →
Stereoisomeric Pyridyl and Pyridonyl Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
12/160,655 →